Sie befinden sich hier: Startseite » Mitglieder » Verordnungen » Arzneimittel A-Z

Arzneimittel A bis Z

Auf dieser Seite erhalten Sie Hinweise zur Verordnungsfähigkeit und Wirtschaftlichkeit von

Arzneimitteln. Hier finden Sie ein Archiv an Artikeln der KV Sachsen, alphabetisch

nach Wirkstoffnamen oder Substanzklasse sortiert.

Weiterhin finden Sie hier zukünftig die Hinweise der gemeinsamen Arbeitsgruppe Arzneimittel der KV Sachsen und der sächsischen Krankenkassen zu den Wirtschaftlichkeitszielen der Arzneimittelvereinbarung. Ergänzend werden Sie „Rote-Hand-Briefe“ und „Wirkstoff

AKTUELL“ der Kassenärztlichen Bundesvereinigung der letzten 3 Jahre finden.

 

A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   X   Z  

 Quelle Stand 

A

Abilify® (Aripiprazol)(62 KB)Wirkstoff AKTUELL 11/2009
Abraxane® (Paclitaxel)(102 KB)Rote-Hand-Brief 01/2014
Aceclofenac (Beofenac®)(137 KB)Rote-Hand-Brief 10/2014
Adempas® (Riociguat)(99 KB)Rote-Hand-Brief 07/2016
Adenuric® (Febuxostat)(98 KB)Wirkstoff AKTUELL 08/2014
Aflibercept (Eylea®)(1,3 MB)Rote-Hand-Brief 04/2021
Aggrenox® (Dipyridamol/ASS)(17 KB)KVSM 04/2014
Agomelatin (Valdoxan®)(57 KB)Wirkstoff AKTUELL 04/2010
AH3® (Hydroxyzin)(214 KB)Rote-Hand-Brief 04/2015
Aktinische Keratose(142 KB)Wirkstoff AKTUELL 05/2017
Alemtuzumab (Lemtrada®)(0,9 MB)Rote-Hand-Brief 01/2020
Alemtuzumab (Lemtrada®)(332 KB)Rote-Hand-Brief 04/2019
Alirocumab (Praluent®)(38 KB)KVSonline 10/2016
Aliskiren (Rasilez®)(19 KB)KVSM 09/2010
Alkindi® (Hydrocortisongranulat)(1,0 MB)Rote-Hand-Brief 02/2021
Ambene® (Phenylbutazon/Lidocain)(29 KB)KVSonline 08/2017
Ambrisentan (Volibris®)(744 KB)Rote-Hand-Brief 06/2012
Ambroxol (Mucosolvan®)(87 KB)Rote-Hand-Brief 08/2013
Anagrelid (Xagrid®)(157 KB)Rote-Hand-Brief 01/2013
Analgetika bei degenerativen Gelenkerkrankungen(1,9 MB)Wirkstoff AKTUELL 10/2019
Ancotil® (Flucytosin)(419 KB)Rote-Hand-Brief 06/2020
Andexanet alfa (Ondexxya®)(775 KB)Rote-Hand-Brief 06/2020
Andexanet alfa (Ondexxya®)(234 KB)Rote-Hand-Brief 11/2020
Anemet® (Dolasetron)(49 KB)Rote-Hand-Brief 02/2011
Angiox® (Bivalirudin)(169 KB)Rote-Hand-Brief 01/2013
Anidulafungin (Ecalta®)(450 KB)Rote-Hand-Brief 01/2020
Anoro® (Umeclidinium/Vilanterol)(139 KB)Wirkstoff AKTUELL 08/2015
Antibiotika, Patienteninformation(132 KB)KBV 04/2012
Antibiotikatherapie bei Harnwegsinfektionen(114 KB)Wirkstoff AKTUELL 09/2017
Antibiotikatherapie bei Infektionen der oberen Atemwege(403 KB)Wirkstoff AKTUELL 12/2011
Antibiotikatherapie bei Infektionen der unteren Atemwege(162 KB)Wirkstoff AKTUELL 02/2017
Antibiotikatherapie in Sachsen(18 KB)KVSM 04/2012
Antibiotikatherapie, Optimierung(262 KB)KVSM 05/2011
Anticholium® (Physostigminsalicylat)(264 KB)Rote-Hand-Brief 05/2020
Antidiabetika, Verordnungseinschränkungen(19 KB)KVSM 09/2010
Anti-D-Immunglobulin (Rhesonativ®)(191 KB)Rote-Hand-Brief 10/2013
Antihistaminika, Regressprophylaxe(75 KB)KVSonline 05/2013
Antikoagulantien, oral(21 KB)KVSM 10/2011
Antikoagulantien(19 KB)KVSM 02/2013
Antiphlogistika/Antirheumatika(18 KB)KVSM 02/2013
Apidra® (Insulinglulisin)(49 KB)Rote-Hand-Brief 09/2011
Apixaban (Eliquis®)(108 KB)Rote-Hand-Brief 09/2013
Apixaban (Eliquis®)(306 KB)Rote-Hand-Brief 05/2019
Apremilast (Otezla®)(200 KB)Wirkstoff AKTUELL 09/2016
Apremilast (Otezla®)(113 KB)Rote-Hand-Brief 11/2016
Arcoxia® (Etoricoxib)(44 KB)Rote-Hand-Brief 07/2016
Aripiprazol (Abilify®)(62 KB)Wirkstoff AKTUELL 11/2009
Arixtra® (Fondaparinux)(161 KB)Wirkstoff AKTUELL 06/2010
Arsentrioxid (Trisenox®)(868 KB)Rote-Hand-Brief 03/2020
Arzerra® (Ofatumumab)(770 KB)Rote-Hand-Brief 12/2013
Arzerra® (Ofatumumab)(234 KB)Rote-Hand-Brief 07/2014
Arzneimittelmarktneuordnungsgesetz (AMNOG)(27 KB)KVSM 02/2011
Arzneimittelrichtlinie FAQ(149 KB)KBV 11/2018
Arzneimitteltherapiesicherheit(5,4 MB)KBV 01/2020
Arzneimittel-Ziele 2020(291 KB)KVSonline 01/2020
Arzneimittelzuzahlungen(19 KB)KVSM 10/2010
Asenapin (Sycrest®)(722 KB)Wirkstoff AKTUELL 11/2013
Atarax® (Hydroxyzin)(214 KB)Rote-Hand-Brief 04/2015
Atezolizumab (Tecentriq®)(328 KB)Rote-Hand-Brief 07/2018
Atezolizumab (Tecentriq®)(558 KB)Rote-Hand-Brief 03/2021
Atomoxetin (Strattera®)(267 KB)Rote-Hand-Brief 12/2011
Atorvastatin Basics®(159 KB)Rote-Hand-Brief 04/2012
Aut-idem(69 KB)KVSonline 01/2015
Aut-idem-Kreuz(21 KB)KVSM 09/2013
Aut-idem-Kreuz(18 KB)KVSM 12/2013
Avastin® (Bevacizumab)(557 KB)Rote-Hand-Brief 05/2010
Avastin® (Bevacizumab)(1,8 MB)Rote-Hand-Brief 11/2010
Avastin® (Bevacizumab)(1,6 MB)Rote-Hand-Brief 05/2013
Azilect® (Rasagilin)(410 KB)Wirkstoff AKTUELL 07/2013
Azithromycin (Ultreon®, Zithromax®)(144 KB)Rote-Hand-Brief 05/2018

nach oben

B

Basiliximab (Simulect®)(173 KB)Rote-Hand-Brief 09/2014
BCG medac(568 KB)Rote-Hand-Brief 03/2020
Becaplermin (Regranex®)(59 KB)Rote-Hand-Brief 03/2010
Beclometason/Formoterol/Glycopyrronium (Trimbow®)(141 KB)Wirkstoff AKTUELL 08/2017
Belimumab (Benlysta®)(200 KB)Rote-Hand-Brief 03/2012
Belimumab (Benlysta®)(522 KB)Rote-Hand-Brief 03/2019
Bendamustin (Levact®)(133 KB)Rote-Hand-Brief 08/2017
Benlysta® (Belimumab)(200 KB)Rote-Hand-Brief 03/2012
Benlysta® (Belimumab)(522 KB)Rote-Hand-Brief 03/2019
Beofenac® (Aceclofenac)(137 KB)Rote-Hand-Brief 10/2014
Berodual® (Ipratropium/Fenoterol)(15 KB)KVSM 06/2013
Beta-Interferone(52 KB)Rote-Hand-Brief 08/2014
Betmiga® (Mirabegron)(292 KB)Wirkstoff AKTUELL 11/2017
Betmiga® (Mirabegron)(158 KB)Rote-Hand-Brief 09/2015
Betäubungsmittel, Verordnungshinweise(30 KB)KVSM 12/2010
Bevacizumab (Avastin®)(557 KB)Rote-Hand-Brief 05/2010
Bevacizumab (Avastin®)(1,8 MB)Rote-Hand-Brief 11/2010
Bevacizumab (Avastin®)(1,6 MB)Rote-Hand-Brief 05/2013
Biologika bei Colitis ulcerosa(2,9 MB)Wirkstoff AKTUELL 08/2020
Biologische Basistherapeutika bei rheumatoider Arthritis(228 KB)Wirkstoff AKTUELL 08/2010
Biologische Basistherapeutika bei rheumatoider Arthritis(2,9 MB)Wirkstoff AKTUELL 04/2020
Biosimilars, Patienteninformation(680 KB)KBV 07/2019
Biosimilars(643 KB)Wirkstoff AKTUELL 01/2021
Biosimilars(351 KB)Wirkstoff AKTUELL 07/2017
Biotin(2,7 MB)Rote-Hand-Brief 05/2019
Bivalirudin (Angiox®)(169 KB)Rote-Hand-Brief 01/2013
Blinatumomab (Blincyto®)(82 KB)Rote-Hand-Brief 10/2016
Blincyto® (Blinatumomab)(82 KB)Rote-Hand-Brief 10/2016
Boceprevir (Victrelis®)(88 KB)Rote-Hand-Brief 02/2012
Bortezomib (Velcade®)(109 KB)Rote-Hand-Brief 01/2012
Bosulif® (Bosutinib)(60 KB)Rote-Hand-Brief 04/2016
Brilique® (Ticagrelor)(20 KB)KVSM 09/2012
Brivudin (Zostex®)(91 KB)Rote-Hand-Brief 08/2012
Brivudin(411 KB)Rote-Hand-Brief 05/2020
Bromocriptin(852 KB)Rote-Hand-Brief 12/2014
BtM-Rezepte, Gemeinschaftspraxis(13 KB)KVSM 07-08/2010
Buccolam® (Midazolam)(103 KB)Rote-Hand-Brief 01/2018
Buccolam® (Midazolam)(110 KB)Rote-Hand-Brief 11/2017

nach oben

C

Caelyx® (Doxorubicin)(101 KB)Rote-Hand-Brief 11/2011
Caelyx® (Doxorubicin)(70 KB)Rote-Hand-Brief 10/2012
Caelyx® (Doxorubicin)(105 KB)Rote-Hand-Brief 09/2011
Caelyx® (Doxorubicin)(104 KB)Rote-Hand-Brief 08/2011
Calcitonin(77 KB)Rote-Hand-Brief 08/2012
Cannabisarzneimittel(2,0 MB)Wirkstoff AKTUELL 08/2019
Capecitabin (Xeloda®)(82 KB)Rote-Hand-Brief 12/2013
Capecitabin(656 KB)Rote-Hand-Brief 06/2020
Capsaicin (Qutenza®)(151 KB)Wirkstoff AKTUELL 08/2010
Carbimazol(387 KB)Rote-Hand-Brief 02/2019
Carbomedac® (Carboplatin)(31 KB)Rote-Hand-Brief 04/2012
Carboplatin onkovis® (Carboplatin)(83 KB)Rote-Hand-Brief 04/2012
Cardioxane® (Dexrazoxan)(1,6 MB)Rote-Hand-Brief 07/2010
Cardioxane® (Dexrazoxan)(65 KB)Rote-Hand-Brief 07/2011
Cefepim (Maxipime®)(76 KB)Rote-Hand-Brief 06/2018
CellCept® (Mycophenolat)(53 KB)Rote-Hand-Brief 12/2014
Cellcept® (Mycophenolatmofetil)(322 KB)Rote-Hand-Brief 11/2015
Ceplene® (Histamindihydrochlorid)(56 KB)Rote-Hand-Brief 12/2011
Cetuximab (Erbitux®)(247 KB)Rote-Hand-Brief 01/2014
Chinolone(404 KB)Rote-Hand-Brief 04/2019
Cidofovir (Vistide®)(77 KB)Rote-Hand-Brief 02/2013
Cidofovir (Vistide®)(78 KB)Rote-Hand-Brief 01/2011
Cilest® (Norgestimat)(96 KB)Rote-Hand-Brief 06/2013
Cilostazol (Pletal®)(19 KB)KVSM 02/2012
Cilostazol (Pletal®)(244 KB)Rote-Hand-Brief 05/2013
Cilostazol (Pletal®)(30 KB)KVSonline 05/2015
Cinacalcet (Mimpara®)(144 KB)Rote-Hand-Brief 03/2013
Cipralex® (Escitalopram)(135 KB)Rote-Hand-Brief 12/2011
Cipramil® (Citalopram)(128 KB)Rote-Hand-Brief 10/2011
Citalopram (Cipramil®)(128 KB)Rote-Hand-Brief 10/2011
Cladribin (Leustatin®, Litak®)(75 KB)Rote-Hand-Brief 12/2017
Clopidogrel(127 KB)Rote-Hand-Brief 08/2013
Cobicistat (Genvoya®, Stribild®,Tybost®)(523 KB)Rote-Hand-Brief 03/2019
Cobimetinib (Cotellic®)(91 KB)Rote-Hand-Brief 04/2017
Comirnaty® (COVID-19-Impfstoff Biontech)(330 KB)Rote-Hand-Brief 07/2021
Cosopt® (Dorzolamid/Timolol)(92 KB)Rote-Hand-Brief 11/2013
Cotellic® (Cobimetinib)(91 KB)Rote-Hand-Brief 04/2017
COVID-19-Impfstoff Janssen(1,1 MB)Rote-Hand-Brief 07/2021
COVID-19-Impfstoff Janssen(625 KB)Rote-Hand-Brief 04/2021
COVID-19-Impfstoffe Biontech/Moderna (Comirnaty®, Spikevax®)(330 KB)Rote-Hand-Brief 07/2021
Crizotinib (Xalkori®)(104 KB)Rote-Hand-Brief 10/2015
Cubicin® (Daptomycin)(233 KB)Rote-Hand-Brief 01/2011
Cyproteronacetat(739 KB)Rote-Hand-Brief 04/2020
Cyproteronacetat/Ethinylestradiol(117 KB)Rote-Hand-Brief 06/2013
Cytarabin (DepoCyte®)(175 KB)Rote-Hand-Brief 07/2013
Cytarabin (DepoCyte®)(166 KB)Rote-Hand-Brief 08/2012
Cytotec® (Misoprostol)(1,0 MB)Rote-Hand-Brief 03/2020

nach oben

D

Dabigatranetexilat (Pradaxa®)(306 KB)Rote-Hand-Brief 05/2019
Dabigatranetexilat (Pradaxa®)(822 KB)Wirkstoff AKTUELL 01/2013
Dabigatranetexilat (Pradaxa®)(265 KB)Rote-Hand-Brief 01/2013
Dabigatranetexilat (Pradaxa®)(108 KB)Rote-Hand-Brief 09/2013
Dabigatranetexilat (Pradaxa®)(63 KB)Wirkstoff AKTUELL 10/2009
Dabigatranetexilat (Pradaxa®)(299 KB)Rote-Hand-Brief 10/2011
Daclatasvir (Daklinza®)(40 KB)Rote-Hand-Brief 05/2015
Daclizumab (Zinbryta®)(219 KB)Rote-Hand-Brief 07/2017
Daclizumab (Zinbryta®)(262 KB)Rote-Hand-Brief 03/2018
Daclizumab (Zinbryta®)(189 KB)Rote-Hand-Brief 08/2018
Daclizumab (Zinbryta®)(263 KB)Rote-Hand-Brief 11/2017
Daklinza® (Daclatasvir)(40 KB)Rote-Hand-Brief 05/2015
Daptomycin (Cubicin®)(233 KB)Rote-Hand-Brief 01/2011
Daratumumab (Darzalex®)(614 KB)Rote-Hand-Brief 06/2019
Darunavir/Cobicistat (Prezista®, Symtuza®)(205 KB)Rote-Hand-Brief 06/2018
Darzalex® (Daratumumab)(614 KB)Rote-Hand-Brief 06/2019
Dasatinib (Sprycel®)(75 KB)Rote-Hand-Brief 08/2011
Dasatinib (Sprycel®)(60 KB)Rote-Hand-Brief 04/2016
Daxas® (Roflumilast)(149 KB)Wirkstoff AKTUELL 06/2011
Denosumab (Prolia®)(168 KB)Wirkstoff AKTUELL 01/2011
Denosumab (Prolia®)(85 KB)Rote-Hand-Brief 02/2013
Denosumab (Prolia®)(195 KB)Wirkstoff AKTUELL 10/2018
Denosumab (Prolia®)(118 KB)Rote-Hand-Brief 09/2014
Denosumab (Xgeva®)(128 KB)Rote-Hand-Brief 09/2014
Denosumab (Xgeva®)(72 KB)Rote-Hand-Brief 07/2015
Denosumab (Xgeva®)(75 KB)Rote-Hand-Brief 09/2012
DepoCyte® (Cytarabin)(166 KB)Rote-Hand-Brief 08/2012
DepoCyte® (Cytarabin)(175 KB)Rote-Hand-Brief 07/2013
Dexamethason (Supertendin®)(65 KB)Rote-Hand-Brief 10/2011
Dexamethason (Supertendin®)(53 KB)Rote-Hand-Brief 11/2011
Dexrazoxan (Cardioxane®)(1,6 MB)Rote-Hand-Brief 07/2010
Dexrazoxan (Cardioxane®)(65 KB)Rote-Hand-Brief 07/2011
Dianeal® (Peritonealdialyse-Lösung)(39 KB)Rote-Hand-Brief 01/2011
Diclofenac(84 KB)Rote-Hand-Brief 07/2013
Dienogest/Ethinylestradiol(169 KB)Rote-Hand-Brief 12/2018
Dihydroergotamin(97 KB)Rote-Hand-Brief 01/2014
Dihydroergotoxin(68 KB)Rote-Hand-Brief 03/2014
Dimethylfumarat (Tecfidera®)(76 KB)Rote-Hand-Brief 12/2014
Dimethylfumarat (Tecfidera®)(181 KB)Rote-Hand-Brief 11/2015
Dimethylfumarat (Tecfidera®)(656 KB)Rote-Hand-Brief 11/2020
Dinoproston (Minprostin®, Prepidil®, Propess®)(1,4 MB)Rote-Hand-Brief 06/2021
Dipyridamol/ASS (Aggrenox®)(17 KB)KVSM 04/2014
Direkte orale Antikoagulanzien (NOAK)(2,8 MB)Wirkstoff AKTUELL 10/2020
Direkte orale Antikoagulanzien (NOAK)(322 KB)Wirkstoff AKTUELL 10/2017
Distraneurin® (Clomethiazol)(20 KB)KVSM 06/2011
Dolasetron (Anemet®)(49 KB)Rote-Hand-Brief 02/2011
Dolutegravir (Juluca®, Tivicay®, Triumeq®)(125 KB)Rote-Hand-Brief 06/2018
Domperidon(83 KB)Rote-Hand-Brief 08/2014
Domperidon(277 KB)Rote-Hand-Brief 04/2019
Doribax® (Doripenem)(81 KB)Rote-Hand-Brief 07/2012
Dorzolamid/Timolol (Cosopt®)(92 KB)Rote-Hand-Brief 11/2013
Doxorubicin (Caelyx®)(101 KB)Rote-Hand-Brief 11/2011
Doxorubicin (Caelyx®)(70 KB)Rote-Hand-Brief 10/2012
Doxorubicin (Caelyx®)(105 KB)Rote-Hand-Brief 09/2011
Doxorubicin (Caelyx®)(104 KB)Rote-Hand-Brief 08/2011
Dronedaron (Multaq®)(790 KB)Wirkstoff AKTUELL 09/2012
Dronedaron (Multaq®)(88 KB)Rote-Hand-Brief 01/2011
Dronedaron (Multaq®)(263 KB)Rote-Hand-Brief 06/2011
Drotrecogin alfa (Xigris®)(115 KB)Rote-Hand-Brief 10/2011
Durogesic® SMAT (Fentanyl)(324 KB)Rote-Hand-Brief 03/2013

nach oben

E

Ecalta® (Anidulafungin)(450 KB)Rote-Hand-Brief 01/2020
Edoxaban (Lixiana®)(306 KB)Rote-Hand-Brief 05/2019
Edronax® (Reboxetin)(17 KB)KVSM 06/2011
Efient® (Prasugrel)(255 KB)Rote-Hand-Brief 12/2013
Efient® (Prasugrel)(33 KB)KVSM 12/2010
Eisenpräparate, i.v. Applikation(103 KB)Rote-Hand-Brief 10/2013
Elektrolyt-Infusionslösungen(132 KB)Rote-Hand-Brief 06/2018
Eligard® (Leuprorelin)(173 KB)Rote-Hand-Brief 12/2017
Eliquis® (Apixaban)(306 KB)Rote-Hand-Brief 05/2019
Eliquis® (Apixaban)(108 KB)Rote-Hand-Brief 09/2013
Elmiron® (Pentosanpolysulfat-Natrium)(1,3 MB)Wirkstoff AKTUELL 02/2019
Elmiron® (Pentosanpolysulfat-Natrium)(202 KB)Rote-Hand-Brief 06/2019
Elvanse® (Lisdexamfetamin)(134 KB)Wirkstoff AKTUELL 10/2015
Elvitegravir (Genvoya®, Stribild®,Tybost®)(523 KB)Rote-Hand-Brief 03/2019
Entyvio® (Vedolizumab)(150 KB)Wirkstoff AKTUELL 10/2016
Epoetin(37 KB)Rote-Hand-Brief 09/2017
Erbitux ® (Cetuximab)(247 KB)Rote-Hand-Brief 01/2014
Erivedge® (Vismodegib)(1,1 MB)Rote-Hand-Brief 07/2013
Erivedge® (Vismodegib)(48 KB)Rote-Hand-Brief 06/2016
Erkältungskrankheiten, Arzneimittel-Verordnungsausschluss(17 KB)KVSM 04/2012
Erlotinib (Tarceva®)(535 KB)Rote-Hand-Brief 01/2016
Esbriet® (Pirfenidon)(508 KB)Rote-Hand-Brief 10/2020
Escitalopram (Cipralex®)(135 KB)Rote-Hand-Brief 12/2011
Eslicarbazepinacetat (Zebinix®)(793 KB)Wirkstoff AKTUELL 11/2012
Esmya® (Ulipristalacetat)(1,0 MB)Rote-Hand-Brief 03/2020
Esmya® (Ulipristalacetat)(134 KB)Rote-Hand-Brief 02/2018
Esmya® (Ulipristalacetat)(357 KB)Rote-Hand-Brief 07/2018
Estradiol (Linoladiol®)(467 KB)Rote-Hand-Brief 02/2020
Ethinylestradiol/Cyproteronacetat(117 KB)Rote-Hand-Brief 06/2013
Ethinylestradiol/Dienogest(169 KB)Rote-Hand-Brief 12/2018
Etonorgestrel (ImplanonNXT®)(196 KB)Rote-Hand-Brief 06/2016
Etoricoxib (Arcoxia®)(44 KB)Rote-Hand-Brief 07/2016
Eucreas® (Vildagliptin)(1,4 MB)Wirkstoff AKTUELL 01/2020
Euthyrox® (Levothyroxin)(715 KB)Rote-Hand-Brief 04/2019
Evicel® (Fibrinkleber)(41 KB)Rote-Hand-Brief 12/2012
Evolocumab (Repatha®)(39 KB)KVSonline 08/2016
Exelon® (Rivastigmin)(54 KB)Wirkstoff AKTUELL 01/2010
Extraneal® (Peritonealdialyse-Lösung)(39 KB)Rote-Hand-Brief 01/2011
Exviera® (Dasabuvir)(348 KB)Rote-Hand-Brief 01/2016
Eylea® (Aflibercept)(1,3 MB)Rote-Hand-Brief 04/2021
Ezetimib (Ezetrol®, Inegy®)(14 KB)KVSM 07/2010
Ezetimib/Simvastatin (Inegy®, Goltor®)(137 KB)Wirkstoff AKTUELL 11/2015
Ezetrol® (Ezetimib)(14 KB)KVSM 07/2010
Fibrinkleber (Evicel®)(41 KB)Rote-Hand-Brief 12/2012

nach oben

F

Febuxostat (Adenuric®)(98 KB)Wirkstoff AKTUELL 08/2014
Febuxostat(799 KB)Rote-Hand-Brief 06/2019
Fenoterol (Partusisten® intrapartal)(81 KB)Rote-Hand-Brief 10/2012
Fenoterol (Partusisten®)(622 KB)Rote-Hand-Brief 09/2013
Fenoterol/Ipratropium (Berodual®)(15 KB)KVSM 06/2013
Fentanyl (Durogesic® SMAT)(324 KB)Rote-Hand-Brief 03/2013
Fentanyl(814 KB)Rote-Hand-Brief 06/2014
Fentanyl®-Janssen(311 KB)Rote-Hand-Brief 03/2013
Filgrastim (Neupogen®)(90 KB)Rote-Hand-Brief 08/2013
Finasterid(400 KB)Rote-Hand-Brief 07/2018
Fingolimod (Gilenya®)(616 KB)Rote-Hand-Brief 09/2019
Fingolimod (Gilenya®)(72 KB)Rote-Hand-Brief 05/2015
Fingolimod (Gilenya®)(118 KB)Rote-Hand-Brief 01/2013
Fingolimod (Gilenya®)(595 KB)Rote-Hand-Brief 02/2021
Fingolimod (Gilenya®)(42 KB)Rote-Hand-Brief 11/2017
Fingolimod (Gilenya®)(117 KB)Rote-Hand-Brief 01/2016
Fingolimod (Gilenya®)(1,6 MB)Rote-Hand-Brief 04/2012
Fingolimod (Gilenya®)(573 KB)Rote-Hand-Brief 01/2012
Fingolimod (Gilenya®)(298 KB)Rote-Hand-Brief 11/2013
Flucytosin (Ancotil®)(419 KB)Rote-Hand-Brief 06/2020
Fluenz® (Influenza-Lebendimpfstoff )(35 KB)KVSM 03/2012
Flunitrazepam(20 KB)KVSonline 11/2011
Fluorchinolone(448 KB)Rote-Hand-Brief 10/2018
Fluorchinolone(2,0 MB)Rote-Hand-Brief 10/2020
Fluorchinolone(404 KB)Rote-Hand-Brief 04/2019
5-Fluorouracil(656 KB)Rote-Hand-Brief 06/2020
Flupigil® (Flupirtin)(85 KB)Rote-Hand-Brief 07/2013
Flupirtin(85 KB)Rote-Hand-Brief 07/2013
Fondaparinux (Arixtra®)(161 KB)Wirkstoff AKTUELL 06/2010
Formoterol/Beclometason/Glycopyrronium (Trimbow®)(141 KB)Wirkstoff AKTUELL 08/2017
Forsteo® (Teriparatid)(170 KB)Wirkstoff AKTUELL 11/2018
Fumaderm®(174 KB)Rote-Hand-Brief 11/2015
Fumaderm®(622 KB)Rote-Hand-Brief 06/2013

nach oben

G

Gadolinium(141 KB)Rote-Hand-Brief 01/2018
Galantaminhydrobromid (Reminyl®)(108 KB)Rote-Hand-Brief 09/2015
Galvus® (Vildagliptin)(1,4 MB)Wirkstoff AKTUELL 01/2020
G-CSF(366 KB)Rote-Hand-Brief 06/2018
Genvoya® (Elvitegravir/Cobicistat/Emtricitabin/Tenofoviralafenamid)(523 KB)Rote-Hand-Brief 03/2019
Gilenya® (Fingolimod)(117 KB)Rote-Hand-Brief 01/2016
Gilenya® (Fingolimod)(298 KB)Rote-Hand-Brief 11/2013
Gilenya® (Fingolimod)(616 KB)Rote-Hand-Brief 09/2019
Gilenya® (Fingolimod)(1,6 MB)Rote-Hand-Brief 04/2012
Gilenya® (Fingolimod)(72 KB)Rote-Hand-Brief 05/2015
Gilenya® (Fingolimod)(118 KB)Rote-Hand-Brief 01/2013
Gilenya® (Fingolimod)(595 KB)Rote-Hand-Brief 02/2021
Gilenya® (Fingolimod)(42 KB)Rote-Hand-Brief 11/2017
Gilenya® (Fingolimod)(573 KB)Rote-Hand-Brief 01/2012
Gliptine, Nutzenbewertung(72 KB)KVSonline 12/2013
Glitazone(17 KB)KVSM 06/2011
Glivec® (Imatinib)(60 KB)Rote-Hand-Brief 04/2016
Glucocorticoide, intraartikuläre Injektion(18 KB)KVSM 01/2013
Glucose-Infusionslösungen(132 KB)Rote-Hand-Brief 06/2018
Glycopyrronium (Seebri® Breezhaler®, Ultibro® Breezhaler®)(100 KB)Wirkstoff AKTUELL 03/2014
Glycopyrronium/Beclometason/Formoterol (Trimbow®)(141 KB)Wirkstoff AKTUELL 08/2017
Goltor® (Simvastatin/Ezetimib)(137 KB)Wirkstoff AKTUELL 11/2015
Granocyte® (Lenograstim)(121 KB)Rote-Hand-Brief 03/2014
Grippeimpfstoffausschreibung 2013/14(15 KB)KVSM 06/2013
Guanfacin (Intuniv®)(155 KB)Wirkstoff AKTUELL 04/2016

nach oben

H

Haldol® (Haloperidol)(137 KB)Rote-Hand-Brief 12/2017
Harvoni® (Sofosbuvir, Ledipasvir)(40 KB)Rote-Hand-Brief 05/2015
HCT(572 KB)Rote-Hand-Brief 10/2018
Herceptin® (Trastuzumab)(70 KB)Rote-Hand-Brief 03/2017
Herceptin® (Trastuzumab)(188 KB)Rote-Hand-Brief 04/2014
HES (Redibag®)(42 KB)Rote-Hand-Brief 07/2013
HES(126 KB)Rote-Hand-Brief 11/2013
Hexaminolevulinat (Hexvix®)(385 KB)Rote-Hand-Brief 12/2011
Hexvix® (Hexaminolevulinat)(385 KB)Rote-Hand-Brief 12/2011
Histamindihydrochlorid (Ceplene®)(56 KB)Rote-Hand-Brief 12/2011
Hörsturztherapie(18 KB)KVSM 03/2011
Hydrocortisongranulat (Alkindi®)(1,0 MB)Rote-Hand-Brief 02/2021
Hydroxyzin (Atarax®, AH3®)(214 KB)Rote-Hand-Brief 04/2015

nach oben

I

humanes Immunglobulin (Vivaglobin®)(153 KB)Rote-Hand-Brief 03/2011
Ibrutinib (Imbruvica®)(136 KB)Rote-Hand-Brief 07/2017
Ibuprofen (Pedea®)(293 KB)Rote-Hand-Brief 07/2013
Icandra® (Vildagliptin)(1,4 MB)Wirkstoff AKTUELL 01/2020
Iclusig® (Ponatinib)(60 KB)Rote-Hand-Brief 04/2016
Idelalisib® (Zydelig)(137 KB)Rote-Hand-Brief 08/2016
Idelalisib (Zydelig®)(124 KB)Rote-Hand-Brief 03/2016
Imatinib (Glivec®)(60 KB)Rote-Hand-Brief 04/2016
Imbruvica® (Ibrutinib)(136 KB)Rote-Hand-Brief 07/2017
Immuntherapeutika bei MS(225 KB)Wirkstoff AKTUELL 12/2015
Imnovid® (Pomalidomid)(108 KB)Rote-Hand-Brief 04/2016
Imnovid® (Pomalidomid)(98 KB)Rote-Hand-Brief 04/2015
Imnovid® (Pomalidomid)(386 KB)Rote-Hand-Brief 08/2013
Impavido® (Miltefosin)(583 KB)Rote-Hand-Brief 02/2021
Impfstoffe, undichte Spritzen(140 KB)Rote-Hand-Brief 04/2018
ImplanonNXT® (Etonorgestrel)(196 KB)Rote-Hand-Brief 06/2016
Incivo® (Telaprevir)(338 KB)Rote-Hand-Brief 04/2013
Inclusig® (Ponatinib)(76 KB)Rote-Hand-Brief 11/2013
Increlex® (Mecasermin)(437 KB)Rote-Hand-Brief 12/2019
Inegy® (Ezetimib)(14 KB)KVSM 07/2010
Inegy® (Simvastatin/Ezetimib)(137 KB)Wirkstoff AKTUELL 11/2015
Infanrix® hexa(126 KB)Rote-Hand-Brief 10/2012
Infanrix® IPV+ Hib(142 KB)Rote-Hand-Brief 10/2012
Influenza-Lebendimpfstoff (Fluenz®)(35 KB)KVSM 03/2012
Informationen der Pharmaindustrie(19 KB)KVSM 07/2012
Ingenolmebutat (Picato®)(362 KB)Rote-Hand-Brief 01/2020
Ingenolmebutat (Picato®)(300 KB)Rote-Hand-Brief 09/2019
Insulinglulisin (Apidra®)(49 KB)Rote-Hand-Brief 09/2011
Intraartikuläre Injektion(18 KB)KVSM 01/2013
Intrauterinpessare(80 KB)Rote-Hand-Brief 07/2015
Intuniv® (Guanfacin)(155 KB)Wirkstoff AKTUELL 04/2016
Invega® (Paliperidon)(272 KB)Rote-Hand-Brief 09/2013
Invirase® (Saquinavir)(74 KB)Rote-Hand-Brief 05/2014
Invirase® (Saquinavir)(1,7 MB)Rote-Hand-Brief 07/2010
Iopromid (Ultravist® 300)(77 KB)Rote-Hand-Brief 11/2012
Ipratropium/Fenoterol (Berodual®)(15 KB)KVSM 06/2013
Irinotecan (Onivyde®)(1,1 MB)Rote-Hand-Brief 10/2019
Ivabradin (Procoralan®)(72 KB)Rote-Hand-Brief 12/2014
Ivabradin (Procoralan®)(755 KB)Wirkstoff AKTUELL 10/2013
Ivabradin (Procoralan®)(67 KB)Rote-Hand-Brief 06/2014
Ivermectin (Solaantra®)(94 KB)Wirkstoff AKTUELL 11/2016

nach oben

J

Janumet® (Sitagliptin)(308 KB)Wirkstoff AKTUELL 05/2018
Januvia® (Sitagliptin)(308 KB)Wirkstoff AKTUELL 05/2018
Johanniskraut-Extrakt, Verordnungsfähigkeit(15 KB)KVSM 01/2010
Juluca® (Dolutegravir/Rilpivirin)(125 KB)Rote-Hand-Brief 06/2018

nach oben

K

Katadolon® (Flupirtin)(85 KB)Rote-Hand-Brief 07/2013
Kepivance® (Palifermin)(286 KB)Rote-Hand-Brief 04/2010
Ketoconazol (Nizoral®)(75 KB)Rote-Hand-Brief 08/2013
Ketoconazol(99 KB)Rote-Hand-Brief 03/2015
Ketoprofen(1,8 MB)Rote-Hand-Brief 08/2010
Keytruda® (Pembrolizumab)(105 KB)Rote-Hand-Brief 07/2018
Kontrazeptiva(534 KB)Rote-Hand-Brief 01/2014
Kontrazeptiva(395 KB)Rote-Hand-Brief 01/2019
Kortisonhaltige Nasensprays, Patienteninformation(53 KB)KBV 02/2017

nach oben

L

Lacosamid (Vimpat®)(96 KB)Wirkstoff AKTUELL 11/2014
Lacosamid (Vimpat®)(33 KB)Rote-Hand-Brief 07/2011
Lactobacillus rhamnosus GG-haltige Arzneimittel(31 KB)KVSonline 11/2017
Laif® 900(18 KB)KVSM 12/2012
Lapatinib (Tyverb®)(786 KB)Rote-Hand-Brief 05/2019
Lariam® (Mefloquin)(1,9 MB)Rote-Hand-Brief 08/2013
Lartruvo® (Olaratumab)(697 KB)Rote-Hand-Brief 05/2019
Ledipasvir (Harvoni®)(40 KB)Rote-Hand-Brief 05/2015
Leflunomid medac®(188 KB)Rote-Hand-Brief 10/2010
Lemtrada® (Alemtuzumab)(332 KB)Rote-Hand-Brief 04/2019
Lemtrada® (Alemtuzumab)(0,9 MB)Rote-Hand-Brief 01/2020
Lenalidomid (Revlimid®)(37 KB)Rote-Hand-Brief 04/2011
Lenalidomid (Revlimid®)(115 KB)Rote-Hand-Brief 06/2013
Lenalidomid (Revlimid®)(228 KB)Rote-Hand-Brief 12/2010
Lenalidomid (Revlimid®)(246 KB)Rote-Hand-Brief 10/2011
Lenalidomid (Revlimid®)(84 KB)Rote-Hand-Brief 12/2012
Lenalidomid (Revlimid®)(108 KB)Rote-Hand-Brief 11/2016
Lenograstim (Granocyte®)(121 KB)Rote-Hand-Brief 03/2014
Lepirudin (Refludan®)(33 KB)Rote-Hand-Brief 01/2010
Letermovir (Prevymis®)(744 KB)Rote-Hand-Brief 09/2020
Leuprorelin (Eligard®)(173 KB)Rote-Hand-Brief 12/2017
Leuprorelin(524 KB)Rote-Hand-Brief 07/2020
Leustatin® (Cladribin)(75 KB)Rote-Hand-Brief 12/2017
Levact® (Bendamustin)(133 KB)Rote-Hand-Brief 08/2017
Levofloxacin (Tavanic®)(141 KB)Rote-Hand-Brief 09/2012
Levothyroxin (Euthyrox®)(715 KB)Rote-Hand-Brief 04/2019
Linoladiol® (Estradiol)(467 KB)Rote-Hand-Brief 02/2020
Linoladiol® N(16 KB)KVSonline 07/2013
Liraglutid (Victoza®)(671 KB)Wirkstoff AKTUELL 01/2018
Lisdexamfetamin (Elvanse®)(134 KB)Wirkstoff AKTUELL 10/2015
Litak® (Cladribin)(75 KB)Rote-Hand-Brief 12/2017
Lixiana® (Edoxaban)(306 KB)Rote-Hand-Brief 05/2019
Lojuxta® (Lomitapid)(1,5 MB)Rote-Hand-Brief 02/2021
"Lomitapid(1,5 MB)
Lucentis® (Ranibizumab)(45 KB)Rote-Hand-Brief 02/2011
Lucentis® (Ranibizumab)(519 KB)Rote-Hand-Brief 08/2019
Lynparza® (Olaparib)(125 KB)Rote-Hand-Brief 05/2018

nach oben

M

MabThera® (Rituximab)(1,7 MB)Rote-Hand-Brief 04/2013
MabThera® (Rituximab)(1,8 MB)Rote-Hand-Brief 08/2011
MabThera® (Rituximab)(54 KB)Rote-Hand-Brief 11/2013
Maxipime® (Cefepim)(76 KB)Rote-Hand-Brief 06/2018
Mecasermin (Increlex®)(437 KB)Rote-Hand-Brief 12/2019
Medikinet® adult (Methylphenidat)(21 KB)KVSM 09/2011
Mefloquin (Lariam®)(1,9 MB)Rote-Hand-Brief 08/2013
Mepact® (Mifamurtid)(586 KB)Rote-Hand-Brief 02/2020
Metamizol(666 KB)Rote-Hand-Brief 12/2020
Methadon, Patienteninformation(48 KB)KBV 10/2017
Methocarbamol (Ortoton®)(337 KB)Wirkstoff AKTUELL 05/2015
Methoxsalen (Uvadex™)(43 KB)Rote-Hand-Brief 12/2011
Methylphenidat (Medikinet® adult)(21 KB)KVSM 09/2011
Metoclopramid, Verkehrsfähigkeit(72 KB)KVSonline 04/2014
Midazolam (Buccolam®)(110 KB)Rote-Hand-Brief 11/2017
Midazolam (Buccolam®)(103 KB)Rote-Hand-Brief 01/2018
Mifamurtid (Mepact®)(586 KB)Rote-Hand-Brief 02/2020
Miltefosin (Impavido®)(583 KB)Rote-Hand-Brief 02/2021
Mimpara® (Cinacalcet)(144 KB)Rote-Hand-Brief 03/2013
Minprostin® (Dinoproston)(1,4 MB)Rote-Hand-Brief 06/2021
Mirabegron (Betmiga®)(292 KB)Wirkstoff AKTUELL 11/2017
Mirabegron (Betmiga®)(158 KB)Rote-Hand-Brief 09/2015
Misodel® (Misoprostol)(109 KB)Rote-Hand-Brief 11/2017
Misoprostol (Cytotec®)(1,0 MB)Rote-Hand-Brief 03/2020
Mistelpräparate(18 KB)KVSM 09/2012
Modafinil (Vigil®)(47 KB)Rote-Hand-Brief 02/2011
Modafinil(172 KB)Rote-Hand-Brief 05/2019
Mucosolvan® (Ambroxol)(87 KB)Rote-Hand-Brief 08/2013
Multaq® (Dronedaron)(88 KB)Rote-Hand-Brief 01/2011
Multaq® (Dronedaron)(790 KB)Wirkstoff AKTUELL 09/2012
Multaq® (Dronedaron)(263 KB)Rote-Hand-Brief 06/2011
Multimedikation(17 KB)KVSM 09/2014
Muskelrelaxantien(16 KB)KVSM 12/2013
Muskelrelaxantien(27 KB)KVSM 10/2019
Mycophenolat (CellCept®)(53 KB)Rote-Hand-Brief 12/2014
Mycophenolat (Myfortic®)(86 KB)Rote-Hand-Brief 02/2016
Mycophenolat(84 KB)Rote-Hand-Brief 02/2018
Mycophenolatmofetil (Cellcept®)(322 KB)Rote-Hand-Brief 11/2015
Myfortic® (Mycophenolat)(86 KB)Rote-Hand-Brief 02/2016

nach oben

N

Naldemedin (Rizmoic®)(358 KB)Wirkstoff AKTUELL 04/2021
Nalmefen (Selincro®)(151 KB)Wirkstoff AKTUELL 10/2015
Natalizumab (Tysabri®)(214 KB)Rote-Hand-Brief 03/2016
Natalizumab (Tysabri®)(1,9 MB)Rote-Hand-Brief 02/2010
Natriumoxybat (Xyrem®)(1,1 MB)Rote-Hand-Brief 08/2010
Neue orale Antikoagulantien, Wirtschaftlichkeit(28 KB)KVSM 11/2013
Neulasta® (Pegfilgrastim)(90 KB)Rote-Hand-Brief 08/2013
Neupogen® (Filgrastim)(90 KB)Rote-Hand-Brief 08/2013
Nikotinsäure/Laropiprant (Tredaptive®)(1,7 MB)Rote-Hand-Brief 01/2013
Nikotinsäure/Laropiprant (Tredaptive®)(1,1 MB)Rote-Hand-Brief 12/2012
Nilotinib (Tasigna®)(60 KB)Rote-Hand-Brief 04/2016
Nipruss(187 KB)Rote-Hand-Brief 05/2013
Nitrate(19 KB)KVSM 09/2011
Nizoral® (Ketoconazol)(75 KB)Rote-Hand-Brief 08/2013
NOAK (Direkte orale Antikoagulanzien)(306 KB)Rote-Hand-Brief 05/2019
NOAK (Direkte orale Antikoagulanzien)(322 KB)Wirkstoff AKTUELL 10/2017
NOAK (Direkte orale Antikoagulanzien)(2,8 MB)Wirkstoff AKTUELL 10/2020
Norgestimat (Cilest®, Pramino®)(96 KB)Rote-Hand-Brief 06/2013
Noxafil® (Posaconazol)(157 KB)Rote-Hand-Brief 07/2016
Nplate® (Romiplostim)(62 KB)Rote-Hand-Brief 09/2011
Nplate® (Romiplostim)(2,1 MB)Rote-Hand-Brief 12/2010
Numeta G13(52 KB)Rote-Hand-Brief 06/2013
Numeta G16(55 KB)Rote-Hand-Brief 10/2013
Nutrineal® (Peritonealdialyse-Lösung)(39 KB)Rote-Hand-Brief 01/2011
Ornanische Nitrate(343 KB)Wirkstoff AKTUELL 04/2021

nach oben

O

Obeticholsäure (Ocaliva®)(92 KB)Rote-Hand-Brief 02/2018
Ocaliva® (Obeticholsäure)(92 KB)Rote-Hand-Brief 02/2018
Octenisept® (Octenidindihydrochlorid, Phenoxyethanol)(1,5 MB)Rote-Hand-Brief 01/2011
Odomzo® (Sonidegib)(46 KB)Rote-Hand-Brief 01/2018
Ofatumumab (Arzerra®)(234 KB)Rote-Hand-Brief 07/2014
Ofatumumab (Arzerra®)(770 KB)Rote-Hand-Brief 12/2013
Olaparib (Lynparza®)(125 KB)Rote-Hand-Brief 05/2018
Olaratumab (Lartruvo®)(697 KB)Rote-Hand-Brief 05/2019
Onasemnogen-Abeparvovec (Zolgensma®)(668 KB)Rote-Hand-Brief 03/2021
Ondansetron (Zofran®)(528 KB)Rote-Hand-Brief 07/2013
Ondansetron(793 KB)Rote-Hand-Brief 10/2019
Ondexxya® (Andexanet alfa)(775 KB)Rote-Hand-Brief 06/2020
Ondexxya® (Andexanet alfa)(234 KB)Rote-Hand-Brief 11/2020
Onivyde® (Irinotecan)(1,1 MB)Rote-Hand-Brief 10/2019
Ortoton® (Methocarbamol)(337 KB)Wirkstoff AKTUELL 05/2015
Otezla® (Apremilast)(200 KB)Wirkstoff AKTUELL 09/2016
Otezla® (Apremilast)(113 KB)Rote-Hand-Brief 11/2016
Oxycodon/Naloxon (Targin®)(764 KB)Wirkstoff AKTUELL 11/2012

nach oben

P

Paclitaxel (Abraxane®)(102 KB)Rote-Hand-Brief 01/2014
Palexia® (Tapentadol)(753 KB)Wirkstoff AKTUELL 06/2012
Palexia® (Tapentadol)(154 KB)Wirkstoff AKTUELL 08/2018
Palifermin (Kepivance®)(286 KB)Rote-Hand-Brief 04/2010
Paliperidon (Invega®, Xeplion®)(272 KB)Rote-Hand-Brief 09/2013
Panitumumab (Vectibix®)(57 KB)Rote-Hand-Brief 05/2011
Panitumumab (Vectibix®)(178 KB)Rote-Hand-Brief 07/2012
Panitumumab (Vectibix®)(269 KB)Rote-Hand-Brief 08/2013
Panitumumab (Vectibix®)(99 KB)Rote-Hand-Brief 04/2010
Panitumumab (Vectibix®)(595 KB)Rote-Hand-Brief 11/2011
Paracetamol i.v. (Perfalgan®)(210 KB)Rote-Hand-Brief 07/2010
Paracetamol i.v. (Perfalgan®)(90 KB)Rote-Hand-Brief 03/2012
Partusisten® (Fenoterol)(622 KB)Rote-Hand-Brief 09/2013
Partusisten® intrapartal (Fenoterol)(81 KB)Rote-Hand-Brief 10/2012
Pazopanib (Votrient®)(53 KB)Rote-Hand-Brief 07/2013
PCSK9-Hemmer (Dokumentationsbogen)(21 KB)KVSonline 05/2020
Pedea® (Ibuprofen)(293 KB)Rote-Hand-Brief 07/2013
Pegfilgrastim (Neulasta®)(90 KB)Rote-Hand-Brief 08/2013
Pembrolizumab (Keytruda®)(105 KB)Rote-Hand-Brief 07/2018
Pentosanpolysulfat-Natrium (Elmiron®)(202 KB)Rote-Hand-Brief 06/2019
Pentosanpolysulfat-Natrium (Elmiron®)(1,3 MB)Wirkstoff AKTUELL 02/2019
Perfalgan® (Paracetamol i.v.)(210 KB)Rote-Hand-Brief 07/2010
Perfalgan® (Paracetamol i.v.)(90 KB)Rote-Hand-Brief 03/2012
Peritonealdialyse-Lösungen (Dianeal®, Extraneal®, Nutrineal®)(39 KB)Rote-Hand-Brief 01/2011
Peritonealdialyse-Lösungen(40 KB)Rote-Hand-Brief 01/2011
Physostigminsalicylat (Anticholium®)(264 KB)Rote-Hand-Brief 05/2020
Picato® (Ingenolmebutat)(362 KB)Rote-Hand-Brief 01/2020
Picato® (Ingenolmebutat)(300 KB)Rote-Hand-Brief 09/2019
Pirfenidon (Esbriet®)(508 KB)Rote-Hand-Brief 10/2020
Piritramid-hameln®(208 KB)Rote-Hand-Brief 07/2012
Pletal® (Cilostazol)(30 KB)KVSonline 05/2015
Pletal® (Cilostazol)(19 KB)KVSM 02/2012
Pletal® (Cilostazol)(244 KB)Rote-Hand-Brief 05/2013
Pneumokokken-Schutzimpfung(23 KB)KVSonline 03/2013
Polypillen (kardiovaskuläre Erkrankungen)(3,2 MB)Wirkstoff AKTUELL 02/2020
Pomalidomid (Imnovid®)(108 KB)Rote-Hand-Brief 04/2016
Pomalidomid (Imnovid®)(386 KB)Rote-Hand-Brief 08/2013
Pomalidomid (Imnovid®)(98 KB)Rote-Hand-Brief 04/2015
Ponatinib (Iclusig®)(60 KB)Rote-Hand-Brief 04/2016
Ponatinib (Inclusig®)(76 KB)Rote-Hand-Brief 11/2013
Posaconazol (Noxafil®)(157 KB)Rote-Hand-Brief 07/2016
Pradaxa® (Dabigatranetexilat)(265 KB)Rote-Hand-Brief 01/2013
Pradaxa® (Dabigatranetexilat)(63 KB)Wirkstoff AKTUELL 10/2009
Pradaxa® (Dabigatranetexilat)(299 KB)Rote-Hand-Brief 10/2011
Pradaxa® (Dabigatranetexilat)(108 KB)Rote-Hand-Brief 09/2013
Pradaxa® (Dabigatranetexilat)(822 KB)Wirkstoff AKTUELL 01/2013
Pradaxa® (Dabigatranetexilat)(306 KB)Rote-Hand-Brief 05/2019
Praluent® (Alirocumab)(38 KB)KVSonline 10/2016
Pramino® (Norgestimat)(96 KB)Rote-Hand-Brief 06/2013
Prasugrel (Efient®)(255 KB)Rote-Hand-Brief 12/2013
Prasugrel (Efient®)(33 KB)KVSM 12/2010
Pregabalin(32 KB)KVSM 02/2015
Prepidil® (Dinoproston)(1,4 MB)Rote-Hand-Brief 06/2021
Prevymis® (Letermovir)(744 KB)Rote-Hand-Brief 09/2020
Prezista® (Darunavir/Cobicistat)(205 KB)Rote-Hand-Brief 06/2018
Procoralan® (Ivabradin)(72 KB)Rote-Hand-Brief 12/2014
Procoralan® (Ivabradin)(67 KB)Rote-Hand-Brief 06/2014
Procoralan® (Ivabradin)(755 KB)Wirkstoff AKTUELL 10/2013
Prolia® (Denosumab)(195 KB)Wirkstoff AKTUELL 10/2018
Prolia® (Denosumab)(85 KB)Rote-Hand-Brief 02/2013
Prolia® (Denosumab)(118 KB)Rote-Hand-Brief 09/2014
Prolia® (Denosumab)(168 KB)Wirkstoff AKTUELL 01/2011
Propess® (Dinoproston)(1,4 MB)Rote-Hand-Brief 06/2021
Protelos® (Strontiumranelat)(80 KB)Rote-Hand-Brief 03/2014
Protelos® (Strontiumranelat)(50 KB)Rote-Hand-Brief 05/2013
Protelos® (Strontiumranelat)(1,5 MB)Rote-Hand-Brief 04/2012
Protonenpumpeninhibitoren, Selbstmedikation(15 KB)KVSM 01/2010
Protonenpumpeninhibitoren(182 KB)KVSM 09/2018
Strontiumranelat (Protelos®)(80 KB)Rote-Hand-Brief 03/2014

nach oben

Q

Qutenza® (Capsaicin)(151 KB)Wirkstoff AKTUELL 08/2010

nach oben

R

Rabattverträge, aut-idem-Kreuz(19 KB)KVSM 12/2012
Radium-223-dichlorid (Xofigo®)(72 KB)Rote-Hand-Brief 03/2018
Raloxifen(98 KB)Wirkstoff AKTUELL 07/2014
Ranexa® (Ranolazin)(146 KB)Wirkstoff AKTUELL 12/2010
Ranibizumab (Lucentis®)(45 KB)Rote-Hand-Brief 02/2011
Ranibizumab (Lucentis®)(519 KB)Rote-Hand-Brief 08/2019
Ranolazin (Ranexa®)(146 KB)Wirkstoff AKTUELL 12/2010
Rapiscan® (Regadenoson)(74 KB)Rote-Hand-Brief 12/2014
Rasagilin (Azilect®)(410 KB)Wirkstoff AKTUELL 07/2013
Rasilez® (Aliskiren)(19 KB)KVSM 09/2010
Reboxetin (Solvex®, Edronax®)(17 KB)KVSM 06/2011
Redibag® (HES)(42 KB)Rote-Hand-Brief 07/2013
Reductil® (Sibutramin)(66 KB)Rote-Hand-Brief 01/2010
Refludan® (Lepirudin)(33 KB)Rote-Hand-Brief 01/2010
Regadenoson (Rapiscan®)(74 KB)Rote-Hand-Brief 12/2014
Regranex® (Becaplermin)(59 KB)Rote-Hand-Brief 03/2010
Reminyl® (Galantaminhydrobromid)(108 KB)Rote-Hand-Brief 09/2015
Repatha® (Evolocumab)(39 KB)KVSonline 08/2016
Retigabin (Trobalt®)(157 KB)Rote-Hand-Brief 06/2013
Retinoide(598 KB)Rote-Hand-Brief 09/2019
Revatio® (Sildenafil)(148 KB)Rote-Hand-Brief 10/2011
Revatio® (Sildenafil)(93 KB)Rote-Hand-Brief 10/2018
Revlimid® (Lenalidomid)(115 KB)Rote-Hand-Brief 06/2013
Revlimid® (Lenalidomid)(108 KB)Rote-Hand-Brief 11/2016
Revlimid® (Lenalidomid)(37 KB)Rote-Hand-Brief 04/2011
Revlimid® (Lenalidomid)(84 KB)Rote-Hand-Brief 12/2012
Revlimid® (Lenalidomid)(228 KB)Rote-Hand-Brief 12/2010
Revlimid® (Lenalidomid)(246 KB)Rote-Hand-Brief 10/2011
Rhesonativ® (Anti-D-Immunglobulin)(191 KB)Rote-Hand-Brief 10/2013
Ribavirin (Virazole®)(53 KB)Rote-Hand-Brief 12/2011
Riociguat (Adempas®)(99 KB)Rote-Hand-Brief 07/2016
Risperdal® (Risperidon)(272 KB)Rote-Hand-Brief 09/2013
Rituximab (MabThera®)(1,7 MB)Rote-Hand-Brief 04/2013
Rituximab (MabThera®)(54 KB)Rote-Hand-Brief 11/2013
Rituximab (MabThera®)(1,8 MB)Rote-Hand-Brief 08/2011
Rivaroxaban (Xarelto®) bei Vorhofflimmern(806 KB)Wirkstoff AKTUELL 03/2013
Rivaroxaban (Xarelto®)(63 KB)Wirkstoff AKTUELL 12/2009
Rivaroxaban (Xarelto®)(108 KB)Rote-Hand-Brief 09/2013
Rivaroxaban (Xarelto®)(148 KB)Rote-Hand-Brief 10/2018
Rivaroxaban (Xarelto®)(306 KB)Rote-Hand-Brief 05/2019
Rivastigmin (Exelon®)(54 KB)Wirkstoff AKTUELL 01/2010
Rizmoic® (Naldemedin)(358 KB)Wirkstoff AKTUELL 04/2021
RoActemra® (Tocilizumab)(1,0 MB)Rote-Hand-Brief 06/2019
RoActemra® (Tocilizumab)(1,7 MB)Rote-Hand-Brief 12/2010
Roflumilast (Daxas®)(149 KB)Wirkstoff AKTUELL 06/2011
Romiplostim (Nplate®)(2,1 MB)Rote-Hand-Brief 12/2010
Romiplostim (Nplate®)(62 KB)Rote-Hand-Brief 09/2011
Rosiglitazon(125 KB)Rote-Hand-Brief 09/2010

nach oben

S

Saccharomyces boulardii(78 KB)Rote-Hand-Brief 01/2018
Safinamid (Xadago®)(123 KB)Wirkstoff AKTUELL 08/2016
Samsca® (Tolvaptan)(564 KB)Rote-Hand-Brief 03/2012
Samsca® (Tolvaptan)(108 KB)Rote-Hand-Brief 05/2013
Saquinavir (Invirase®)(1,7 MB)Rote-Hand-Brief 07/2010
Saquinavir (Invirase®)(74 KB)Rote-Hand-Brief 05/2014
Schmerzmittel, Anwendungseinschränkungen(22 KB)KVSM 01/2014
Schmerzmittel, Anwendungseinschränkungen(19 KB)KVSonline 08/2013
Schwefelhexafluorid (SonoVue®)(342 KB)Rote-Hand-Brief 12/2014
Seebri® Breezhaler® (Glycopyrronium)(100 KB)Wirkstoff AKTUELL 03/2014
Selexipag (Uptravi®)(51 KB)Rote-Hand-Brief 06/2017
Selincro® (Nalmefen)(151 KB)Wirkstoff AKTUELL 10/2015
SGLT2-Inhibitoren(248 KB)Rote-Hand-Brief 01/2019
Sibutramin (Reductil®)(66 KB)Rote-Hand-Brief 01/2010
Sildenafil (Revatio®, Viagra®)(93 KB)Rote-Hand-Brief 10/2018
Sildenafil (Revatio®)(148 KB)Rote-Hand-Brief 10/2011
Silodosin (Urorec®)(143 KB)Wirkstoff AKTUELL 02/2011
Simulect® (Basiliximab)(173 KB)Rote-Hand-Brief 09/2014
Simvastatin/Ezetimib (Inegy®, Goltor®)(137 KB)Wirkstoff AKTUELL 11/2015
Sitagliptin (Januvia®, Janumet®, Velmetia®, Xelevia®)(308 KB)Wirkstoff AKTUELL 05/2018
Sitaxentan (Thelin®)(101 KB)Rote-Hand-Brief 12/2010
Sofosbuvir (Sovaldi®, Harvoni®)(40 KB)Rote-Hand-Brief 05/2015
Solaantra® (Ivermectin)(94 KB)Wirkstoff AKTUELL 11/2016
Solvex® (Reboxetin)(17 KB)KVSM 06/2011
Sonidegib (Odomzo®)(46 KB)Rote-Hand-Brief 01/2018
SonoVue® (Schwefelhexafluorid)(342 KB)Rote-Hand-Brief 12/2014
Sovaldi® (Sofosbuvir)(40 KB)Rote-Hand-Brief 05/2015
Spikevax® (COVID-19-Impfstoff Moderna)(330 KB)Rote-Hand-Brief 07/2021
Sprycel® (Dasatinib)(60 KB)Rote-Hand-Brief 04/2016
Sprycel® (Dasatinib)(75 KB)Rote-Hand-Brief 08/2011
Stavudin (Zerit®)(56 KB)Rote-Hand-Brief 03/2011
Stückelungsregelung(17 KB)KVSM 03/2011
Stückzahlen, Abgaberegelungen(19 KB)KVSM 12/2012
Stelara® (Ustekinumab)(155 KB)Rote-Hand-Brief 11/2014
Stelara® (Ustekinumab)(712 KB)Wirkstoff AKTUELL 01/2014
Strattera® (Atomoxetin)(267 KB)Rote-Hand-Brief 12/2011
Stribild® (Elvitegravir/Cobicistat/Emtricitabin/Tenofovirdisoproxil)(523 KB)Rote-Hand-Brief 03/2019
Strimvelis®(419 KB)Rote-Hand-Brief 03/2021
Strontiumranelat (Protelos®)(50 KB)Rote-Hand-Brief 05/2013
Strontiumranelat (Protelos®)(1,5 MB)Rote-Hand-Brief 04/2012
Substitutions-Ausschluss(69 KB)KVSonline 01/2015
Substitutionsregeln in der Arzneimittelverordnung(21 KB)KVSM 05/2012
Sunitinib (Sutent®)(1,4 MB)Rote-Hand-Brief 11/2010
Supertendin® (Dexamethason)(53 KB)Rote-Hand-Brief 11/2011
Supertendin® (Dexamethason)(65 KB)Rote-Hand-Brief 10/2011
Sutent® (Sunitinib)(1,4 MB)Rote-Hand-Brief 11/2010
Sycrest® (Asenapin)(722 KB)Wirkstoff AKTUELL 11/2013
Symtuza® (Darunavir/Cobicistat)(205 KB)Rote-Hand-Brief 06/2018
Synthetische Basistherapeutika bei rheumatoider Arthritis(3,3 MB)Wirkstoff AKTUELL 10/2020

nach oben

T

Tapentadol (Palexia®)(753 KB)Wirkstoff AKTUELL 06/2012
Tapentadol (Palexia®)(154 KB)Wirkstoff AKTUELL 08/2018
Tarceva® (Erlotinib)(535 KB)Rote-Hand-Brief 01/2016
Targin® (Oxycodon/Naloxon)(764 KB)Wirkstoff AKTUELL 11/2012
Tasigna® (Nilotinib)(60 KB)Rote-Hand-Brief 04/2016
Tavanic® (Levofloxacin)(141 KB)Rote-Hand-Brief 09/2012
Tecentriq® (Atezolizumab)(558 KB)Rote-Hand-Brief 03/2021
Tecentriq® (Atezolizumab)(328 KB)Rote-Hand-Brief 07/2018
Tecfidera® (Dimethylfumarat )(656 KB)Rote-Hand-Brief 11/2020
Tecfidera® (Dimethylfumarat )(181 KB)Rote-Hand-Brief 11/2015
Tecfidera® (Dimethylfumarat)(76 KB)Rote-Hand-Brief 12/2014
Tegafur(656 KB)Rote-Hand-Brief 06/2020
Telaprevir (Incivo®)(338 KB)Rote-Hand-Brief 04/2013
Telavancin (Vibativ®)(85 KB)Rote-Hand-Brief 01/2015
Temozolomid Hexal® (Temozolomid )(74 KB)Rote-Hand-Brief 07/2010
Temozolomid Hospira® (Temozolomid )(40 KB)Rote-Hand-Brief 07/2010
Temozolomid(66 KB)Rote-Hand-Brief 12/2013
Temsirolimus (Torisel®)(302 KB)Rote-Hand-Brief 12/2011
Teriparatid (Forsteo®)(170 KB)Wirkstoff AKTUELL 11/2018
Tetrazepam(331 KB)Rote-Hand-Brief 06/2013
Thalidomid(52 KB)Rote-Hand-Brief 11/2015
Thalidomide Celgene™(118 KB)Rote-Hand-Brief 06/2016
Thalidomide Celgene™(51 KB)Rote-Hand-Brief 04/2011
Thalidomide Celgene™(230 KB)Rote-Hand-Brief 04/2013
Thelin® (Sitaxentan)(101 KB)Rote-Hand-Brief 12/2010
Thiamazol(387 KB)Rote-Hand-Brief 02/2019
Thromboseprophylaxe, medikamentöse(25 KB)KVSM 10/2010
Ticagrelor (Brilique®)(20 KB)KVSM 09/2012
Tigecyclin (Tygacil®)(48 KB)Rote-Hand-Brief 03/2011
Tilidin, BtM-Pflicht(20 KB)KVSM 11/2012
Timolol/Dorzolamid (Cosopt®)(92 KB)Rote-Hand-Brief 11/2013
Tivicay® (Dolutegravir)(125 KB)Rote-Hand-Brief 06/2018
TNF-alpha-Hemmer(13 KB)KVSM 09/2014
Tocilizumab (RoActemra®)(1,0 MB)Rote-Hand-Brief 06/2019
Tocilizumab (RoActemra®)(1,7 MB)Rote-Hand-Brief 12/2010
Tofacitinib (Xeljanz®)(870 KB)Rote-Hand-Brief 05/2019
Tofacitinib (Xeljanz®)(719 KB)Rote-Hand-Brief 03/2019
Tofacitinib (Xeljanz®)(1,4 MB)Rote-Hand-Brief 03/2021
Tofacitinib (Xeljanz®)(0,9 MB)Rote-Hand-Brief 03/2020
Tofacitinib (Xeljanz®)(1,3 MB)Rote-Hand-Brief 07/2021
Tolperison(22 KB)Rote-Hand-Brief 02/2013
Tolperison(472 KB)Rote-Hand-Brief 06/2020
Tolvaptan (Samsca®)(108 KB)Rote-Hand-Brief 05/2013
Tolvaptan (Samsca®)(564 KB)Rote-Hand-Brief 03/2012
Torisel® (Temsirolimus)(302 KB)Rote-Hand-Brief 12/2011
Trancolong® (Flupirtin)(85 KB)Rote-Hand-Brief 07/2013
Trancopal® (Flupirtin)(85 KB)Rote-Hand-Brief 07/2013
Trastuzumab (Herceptin®)(70 KB)Rote-Hand-Brief 03/2017
Trastuzumab (Herceptin®)(188 KB)Rote-Hand-Brief 04/2014
Tredaptive® (Nikotinsäure/Laropiprant)(1,1 MB)Rote-Hand-Brief 12/2012
Tredaptive® (Nikotinsäure/Laropiprant)(1,7 MB)Rote-Hand-Brief 01/2013
Triamcinolon(32 KB)KVSM 02/2015
Trimbow® (Beclometason/Formoterol/Glycopyrronium)(141 KB)Wirkstoff AKTUELL 08/2017
Trisenox® (Arsentrioxid)(868 KB)Rote-Hand-Brief 03/2020
Triumeq® (Dolutegravir/Abacavir/Lamivudin)(125 KB)Rote-Hand-Brief 06/2018
Trobalt® (Retigabin)(157 KB)Rote-Hand-Brief 06/2013
Tybost® (Cobicistat)(523 KB)Rote-Hand-Brief 03/2019
Tygacil® (Tigecyclin)(48 KB)Rote-Hand-Brief 03/2011
Typhim Vi® (Typhus-Polysaccharid-Impfstoff)(66 KB)Rote-Hand-Brief 09/2012
Tysabri® (Natalizumab)(214 KB)Rote-Hand-Brief 03/2016
Tysabri® (Natalizumab)(1,9 MB)Rote-Hand-Brief 02/2010
Tyverb® (Lapatinib)(786 KB)Rote-Hand-Brief 05/2019

nach oben

U

Ulipristalacetat (Esmya®)(357 KB)Rote-Hand-Brief 07/2018
Ulipristalacetat (Esmya®)(1,0 MB)Rote-Hand-Brief 03/2020
Ulipristalacetat (Esmya®)(134 KB)Rote-Hand-Brief 02/2018
Ulipristalacetat(1,4 MB)Rote-Hand-Brief 02/2021
Ultibro® Breezhaler® (Glycopyrronium)(100 KB)Wirkstoff AKTUELL 03/2014
Ultravist® 300 (Iopromid)(77 KB)Rote-Hand-Brief 11/2012
Ultreon® (Azithromycin)(144 KB)Rote-Hand-Brief 05/2018
Umeclidinium/Vilanterol (Anoro®)(139 KB)Wirkstoff AKTUELL 08/2015
Uptravi® (Selexipag)(51 KB)Rote-Hand-Brief 06/2017
Urologische Spasmolytika(758 KB)Wirkstoff AKTUELL 07/2013
Urorec® (Silodosin)(143 KB)Wirkstoff AKTUELL 02/2011
Ustekinumab (Stelara®)(155 KB)Rote-Hand-Brief 11/2014
Ustekinumab (Stelara®)(712 KB)Wirkstoff AKTUELL 01/2014
Uvadex™ (Methoxsalen)(43 KB)Rote-Hand-Brief 12/2011

nach oben

V

"COVID-19-Impfstoff AstraZeneca(105 KB)
"COVID-19-Impfstoff AstraZeneca(135 KB)
Valdoxan® (Agomelatin)(57 KB)Wirkstoff AKTUELL 04/2010
Valproat(1,6 MB)Rote-Hand-Brief 12/2014
Valproat(0,9 MB)Rote-Hand-Brief 11/2018
Vaxzevria® (COVID-19-Impfstoff AstraZeneca)(135 KB)Rote-Hand-Brief 06/2021
Vaxzevria® (COVID-19-Impfstoff AstraZeneca)(105 KB)Rote-Hand-Brief 04/2021
Vectibix® (Panitumumab)(595 KB)Rote-Hand-Brief 11/2011
Vectibix® (Panitumumab)(57 KB)Rote-Hand-Brief 05/2011
Vectibix® (Panitumumab)(99 KB)Rote-Hand-Brief 04/2010
Vectibix® (Panitumumab)(178 KB)Rote-Hand-Brief 07/2012
Vectibix® (Panitumumab)(269 KB)Rote-Hand-Brief 08/2013
Vedolizumab (Entyvio®)(150 KB)Wirkstoff AKTUELL 10/2016
Velcade® (Bortezomib)(109 KB)Rote-Hand-Brief 01/2012
Velmetia® (Sitagliptin)(308 KB)Wirkstoff AKTUELL 05/2018
Vemurafenib (Zelboraf®)(112 KB)Rote-Hand-Brief 08/2013
Vemurafenib (Zelboraf®)(238 KB)Rote-Hand-Brief 10/2015
Venclyxto® (Venetoclax)(475 KB)Rote-Hand-Brief 06/2021
Venetoclax (Venclyxto®)(475 KB)Rote-Hand-Brief 06/2021
Verbandstoffe, Verordnungsfähigkeit(15 KB)KVSM 11/2014
Verbandstoff-Liste(104 KB)KVSM 09/2019
Verordnungsfähigkeit nach AM-RL(504 KB)KBV 06/2018
Verordnungsfähigkeit nach AM-RL(302 KB)KBV 04/2014
Viagra® (Sildenafil)(93 KB)Rote-Hand-Brief 10/2018
Vibativ® (Telavancin)(85 KB)Rote-Hand-Brief 01/2015
Victoza® (Liraglutid)(671 KB)Wirkstoff AKTUELL 01/2018
Victrelis® (Boceprevir)(88 KB)Rote-Hand-Brief 02/2012
Viekirax® (Ombitasvir, Paritaprevir, Ritonavir)(348 KB)Rote-Hand-Brief 01/2016
Vigil® (Modafinil)(47 KB)Rote-Hand-Brief 02/2011
Vilanterol/Umeclidinium (Anoro®)(139 KB)Wirkstoff AKTUELL 08/2015
Vildagliptin (Galvus®, Eucreas®, Icandra®)(1,4 MB)Wirkstoff AKTUELL 01/2020
Vimpat® (Lacosamid)(33 KB)Rote-Hand-Brief 07/2011
Vimpat® (Lacosamid)(96 KB)Wirkstoff AKTUELL 11/2014
Virazole® (Ribavirin)(53 KB)Rote-Hand-Brief 12/2011
Vismodegib (Erivedge®)(1,1 MB)Rote-Hand-Brief 07/2013
Vismodegib (Erivedge®)(48 KB)Rote-Hand-Brief 06/2016
Vistide® (Cidofovir)(78 KB)Rote-Hand-Brief 01/2011
Vistide® (Cidofovir)(77 KB)Rote-Hand-Brief 02/2013
Vitamin D-Monopräparate(22 KB)KVSonline 04/2013
Vivaglobin® (humanes Immunglobulin)(153 KB)Rote-Hand-Brief 03/2011
Volibris® (Ambrisentan)(744 KB)Rote-Hand-Brief 06/2012
Votrient® (Pazopanib)(53 KB)Rote-Hand-Brief 07/2013

nach oben

X

Xadago® (Safinamid)(123 KB)Wirkstoff AKTUELL 08/2016
Xagrid® (Anagrelid)(157 KB)Rote-Hand-Brief 01/2013
Xalkori® (Crizotinib)(104 KB)Rote-Hand-Brief 10/2015
Xarelto® (Rivaroxaban) bei Vorhofflimmern(806 KB)Wirkstoff AKTUELL 03/2013
Xarelto® (Rivaroxaban)(63 KB)Wirkstoff AKTUELL 12/2009
Xarelto® (Rivaroxaban)(306 KB)Rote-Hand-Brief 05/2019
Xarelto® (Rivaroxaban)(108 KB)Rote-Hand-Brief 09/2013
Xarelto® (Rivaroxaban)(148 KB)Rote-Hand-Brief 10/2018
Xelevia® (Sitagliptin)(308 KB)Wirkstoff AKTUELL 05/2018
Xeljanz® (Tofacitinib)(719 KB)Rote-Hand-Brief 03/2019
Xeljanz® (Tofacitinib)(1,3 MB)Rote-Hand-Brief 07/2021
Xeljanz® (Tofacitinib)(1,4 MB)Rote-Hand-Brief 03/2021
Xeljanz® (Tofacitinib)(0,9 MB)Rote-Hand-Brief 03/2020
Xeljanz® (Tofacitinib)(870 KB)Rote-Hand-Brief 05/2019
Xeloda® (Capecitabin)(82 KB)Rote-Hand-Brief 12/2013
Xeplion® (Paliperidon)(272 KB)Rote-Hand-Brief 09/2013
Xgeva® (Denosumab)(72 KB)Rote-Hand-Brief 07/2015
Xgeva® (Denosumab)(75 KB)Rote-Hand-Brief 09/2012
Xgeva® (Denosumab)(128 KB)Rote-Hand-Brief 09/2014
Xigris® (Drotrecogin alfa)(115 KB)Rote-Hand-Brief 10/2011
Xofigo® (Radium-223-dichlorid)(72 KB)Rote-Hand-Brief 03/2018
Xyrem® (Natriumoxybat)(1,1 MB)Rote-Hand-Brief 08/2010

nach oben

Z

Zebinix® (Eslicarbazepinacetat)(793 KB)Wirkstoff AKTUELL 11/2012
Zelboraf® (Vemurafenib)(238 KB)Rote-Hand-Brief 10/2015
Zelboraf® (Vemurafenib)(112 KB)Rote-Hand-Brief 08/2013
Zerit® (Stavudin)(56 KB)Rote-Hand-Brief 03/2011
Zinbryta® (Daclizumab)(219 KB)Rote-Hand-Brief 07/2017
Zinbryta® (Daclizumab)(262 KB)Rote-Hand-Brief 03/2018
Zinbryta® (Daclizumab)(263 KB)Rote-Hand-Brief 11/2017
Zinbryta® (Daclizumab)(189 KB)Rote-Hand-Brief 08/2018
Zithromax® (Azithromycin)(144 KB)Rote-Hand-Brief 05/2018
Zofran® (Ondansetron)(528 KB)Rote-Hand-Brief 07/2013
Zolgensma® (Onasemnogen-Abeparvovec)(668 KB)Rote-Hand-Brief 03/2021
Zostex® (Brivudin)(411 KB)Rote-Hand-Brief 05/2020
Zostex® (Brivudin)(91 KB)Rote-Hand-Brief 08/2012
Zydelig (Idelalisib®)(137 KB)Rote-Hand-Brief 08/2016
Zydelig® (Idelalisib)(124 KB)Rote-Hand-Brief 03/2016

nach oben